Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial.

Andrea de Bejczy; Elin Löf; Lisa Walther; Joar Guterstam; Anders Hammarberg; Gulber Asanovska; Johan Franck; Anders Isaksson; Bo Söderpalm

doi:10.1111/acer.12854

Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial.

Andrea de Bejczy, Elin Löf, Lisa Walther, Joar Guterstam, Anders Hammarberg, Gulber Asanovska, Johan Franck, Anders Isaksson, Bo Söderpalm

Division of Clinical Chemistry and Pharmacology

Research output: Contribution to journal › Article › peer-review

Abstract

Alcohol dependence is a devastating illness affecting a large population, and new pharmacological treatments with good efficacy are greatly needed. One potential candidate is varenicline, a smoking cessation agent with partial agonist action at α4 β2 nicotinic acetylcholine receptors.

Original language	English
Pages (from-to)	2189-2199
Journal	Alcoholism: Clinical and Experimental Research
Volume	39
Issue number	11
DOIs	https://doi.org/10.1111/acer.12854
Publication status	Published - 2015

Subject classification (UKÄ)

Substance Abuse

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/acer.12854

http://www.ncbi.nlm.nih.gov/pubmed/26414337?dopt=Abstract

Cite this

@article{0c5a78cf87614c2a9139c2cb0cd9069e,

title = "Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial.",

abstract = "Alcohol dependence is a devastating illness affecting a large population, and new pharmacological treatments with good efficacy are greatly needed. One potential candidate is varenicline, a smoking cessation agent with partial agonist action at α4 β2 nicotinic acetylcholine receptors.",

author = "{de Bejczy}, Andrea and Elin L{\"o}f and Lisa Walther and Joar Guterstam and Anders Hammarberg and Gulber Asanovska and Johan Franck and Anders Isaksson and Bo S{\"o}derpalm",

year = "2015",

doi = "10.1111/acer.12854",

language = "English",

volume = "39",

pages = "2189--2199",

journal = "Alcoholism: Clinical and Experimental Research",

issn = "0145-6008",

publisher = "John Wiley & Sons Inc.",

number = "11",

}

TY - JOUR

T1 - Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial.

AU - de Bejczy, Andrea

AU - Löf, Elin

AU - Walther, Lisa

AU - Guterstam, Joar

AU - Hammarberg, Anders

AU - Asanovska, Gulber

AU - Franck, Johan

AU - Isaksson, Anders

AU - Söderpalm, Bo

PY - 2015

Y1 - 2015

N2 - Alcohol dependence is a devastating illness affecting a large population, and new pharmacological treatments with good efficacy are greatly needed. One potential candidate is varenicline, a smoking cessation agent with partial agonist action at α4 β2 nicotinic acetylcholine receptors.

AB - Alcohol dependence is a devastating illness affecting a large population, and new pharmacological treatments with good efficacy are greatly needed. One potential candidate is varenicline, a smoking cessation agent with partial agonist action at α4 β2 nicotinic acetylcholine receptors.

U2 - 10.1111/acer.12854

DO - 10.1111/acer.12854

M3 - Article

C2 - 26414337

SN - 0145-6008

VL - 39

SP - 2189

EP - 2199

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

IS - 11

ER -

Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial.

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Cite this